Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide.
from : World https://ift.tt/8CcS2dA
Post a Comment
0Comments
3/related/default
0Comments
Copyright (c) 2023 QuickNEWSAlert All Right Reseved